Please use this identifier to cite or link to this item:
Title: Polymer Drug Conjugation for New Concept Chemotherapy
Authors: CHAW SU YIN
Keywords: Prodrug, Polymer drug conjugation, Nanomedicine, Biodegradable polymers, Drug Delivery, Cancer nanotechnology
Issue Date: 20-Jan-2011
Citation: CHAW SU YIN (2011-01-20). Polymer Drug Conjugation for New Concept Chemotherapy. ScholarBank@NUS Repository.
Abstract: This research developed a novel prodrug conjugation of Docetaxel (DTX) to d-a-tocopheryl polyethylene glycol succinate (TPGS) in an attempt to eliminate the use of the toxic adjuvant in the current formulation, Taxotere®. TPGS-DTX conjugate was prepared by a two step synthesis and was characterized by 1H NMR and GPC to ensure that conjugation has taken place. In vitro cytotoxicity of TPGS-DTX conjugate was evaluated by MTT assay against MCF-7 breast cancer cell lines. From the IC50 values, the conjugate was found to be 30.9% and 98.6% more effective when cultured with MCF-7 cells for 48 and 72 h respectively in comparison with Taxotere®. In addition, in vivo pharmacokinetics studies showed that the t1/2 of TPGS-DTX was found to be 23-fold longer than that for Taxotere® and the total area-under-curve for TPGS-DTX was 8.6-fold larger than that of Taxotere®, indicating that the prodrug formulation has higher therapeutic effect than Taxotere®.
Appears in Collections:Master's Theses (Open)

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
ChawSY.pdf1.65 MBAdobe PDF



Page view(s)

checked on Nov 24, 2018


checked on Nov 24, 2018

Google ScholarTM


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.